239 related articles for article (PubMed ID: 19372582)
1. Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity.
Kasiappan R; Shih HJ; Chu KL; Chen WT; Liu HP; Huang SF; Choy CO; Shu CL; Din R; Chu JS; Hsu HL
Mol Cancer Res; 2009 Apr; 7(4):536-48. PubMed ID: 19372582
[TBL] [Abstract][Full Text] [Related]
2. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
Gorgoulis VG; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos PJ; Kittas C; Field JK
Cancer Res; 2001 Jan; 61(2):538-49. PubMed ID: 11212247
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
[TBL] [Abstract][Full Text] [Related]
4. MCT-1 oncogene downregulates p53 and destabilizes genome structure in the response to DNA double-strand damage.
Hsu HL; Choy CO; Kasiappan R; Shih HJ; Sawyer JR; Shu CL; Chu KL; Chen YR; Hsu HF; Gartenhaus RB
DNA Repair (Amst); 2007 Sep; 6(9):1319-32. PubMed ID: 17416211
[TBL] [Abstract][Full Text] [Related]
5. A mouse model for cyclin E-dependent genetic instability and tumorigenesis.
Loeb KR; Kostner H; Firpo E; Norwood T; D Tsuchiya K; Clurman BE; Roberts JM
Cancer Cell; 2005 Jul; 8(1):35-47. PubMed ID: 16023597
[TBL] [Abstract][Full Text] [Related]
6. Centrosome abnormalities in non-small cell lung cancer: correlations with DNA aneuploidy and expression of cell cycle regulatory proteins.
Jung CK; Jung JH; Lee KY; Kang CS; Kim M; Ko YH; Oh CS
Pathol Res Pract; 2007; 203(12):839-47. PubMed ID: 17913384
[TBL] [Abstract][Full Text] [Related]
7. Etoposide (VP-16) elicits apoptosis following prolonged G2-M cell arrest in p53-mutated human non-small cell lung cancer cells.
Chiu CC; Li CH; Ung MW; Fuh TS; Chen WL; Fang K
Cancer Lett; 2005 Jun; 223(2):249-58. PubMed ID: 15896459
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of MCT-1 by p44/42 MAPK is required for its stabilization in response to DNA damage.
Nandi S; Reinert LS; Hachem A; Mazan-Mamczarz K; Hagner P; He H; Gartenhaus RB
Oncogene; 2007 Apr; 26(16):2283-9. PubMed ID: 17016429
[TBL] [Abstract][Full Text] [Related]
9. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
Woo RA; Poon RY
Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
[TBL] [Abstract][Full Text] [Related]
10. BAG-1 haplo-insufficiency impairs lung tumorigenesis.
Götz R; Kramer BW; Camarero G; Rapp UR
BMC Cancer; 2004 Nov; 4():85. PubMed ID: 15560850
[TBL] [Abstract][Full Text] [Related]
11. The antagonism between MCT-1 and p53 affects the tumorigenic outcomes.
Kasiappan R; Shih HJ; Wu MH; Choy C; Lin TD; Chen L; Hsu HL
Mol Cancer; 2010 Dec; 9():311. PubMed ID: 21138557
[TBL] [Abstract][Full Text] [Related]
12. Reduced telomeric signals and increased telomeric associations in human lung cancer cell lines undergoing p53-mediated apoptosis.
Mukhopadhyay T; Multani AS; Roth JA; Pathak S
Oncogene; 1998 Aug; 17(7):901-6. PubMed ID: 9780006
[TBL] [Abstract][Full Text] [Related]
13. The candidate tumor suppressor ING1b can stabilize p53 by disrupting the regulation of p53 by MDM2.
Leung KM; Po LS; Tsang FC; Siu WY; Lau A; Ho HT; Poon RY
Cancer Res; 2002 Sep; 62(17):4890-3. PubMed ID: 12208736
[TBL] [Abstract][Full Text] [Related]
14. Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells.
Cheng Y; Qiu F; Ye YC; Tashiro S; Onodera S; Ikejima T
Arch Biochem Biophys; 2009 Oct; 490(1):70-5. PubMed ID: 19699177
[TBL] [Abstract][Full Text] [Related]
15. Effect of isoverbascoside, a phenylpropanoid glycoside antioxidant, on proliferation and differentiation of human gastric cancer cell.
Chen RC; Su JH; Yang SM; Li J; Wang TJ; Zhou H
Acta Pharmacol Sin; 2002 Nov; 23(11):997-1001. PubMed ID: 12421475
[TBL] [Abstract][Full Text] [Related]
16. Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228.
Yu X; Guo ZS; Marcu MG; Neckers L; Nguyen DM; Chen GA; Schrump DS
J Natl Cancer Inst; 2002 Apr; 94(7):504-13. PubMed ID: 11929951
[TBL] [Abstract][Full Text] [Related]
17. NBS1 is required for IGF-1 induced cellular proliferation through the Ras/Raf/MEK/ERK cascade.
Hematulin A; Sagan D; Eckardt-Schupp F; Moertl S
Cell Signal; 2008 Dec; 20(12):2276-85. PubMed ID: 18793719
[TBL] [Abstract][Full Text] [Related]
18. p53-mediated regulation of cell cycle progression: pronounced impact of cellular microenvironment.
Schmid G; Kramer MP; Wesierska-Gadek J
J Cell Physiol; 2009 May; 219(2):459-69. PubMed ID: 19170070
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes.
Sasaki R; Narisawa-Saito M; Yugawa T; Fujita M; Tashiro H; Katabuchi H; Kiyono T
Carcinogenesis; 2009 Mar; 30(3):423-31. PubMed ID: 19126650
[TBL] [Abstract][Full Text] [Related]
20. Expression and stabilization of the MCT-1 protein by DNA damaging agents.
Herbert GB; Shi B; Gartenhaus RB
Oncogene; 2001 Oct; 20(46):6777-83. PubMed ID: 11709712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
